Grifols | GRFS - Market Capitalization


Grifols reported EUR1.86B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Arca Biopharma USD 2.43B 963M Mar/2026
Bio Path USD 1000K 0 Mar/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cara Therapeutics USD 30M 336M Mar/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Immunic USD 64M 23M Dec/2025
Nektar Therapeutics USD 2.12B 1.26B Mar/2026